Assessment of Consensus-Based Pharmacological Therapies in Irritable Bowel Syndrome

Abstract

Context: The irritable bowel syndrome (IBS) is a symptom-based gastrointestinal (GI) disease with the presence of symptoms such as abdominal pain and abnormal intestinal activities. It is a frequent GI problem encountered by physicians. The purpose of this paper was to review and assess some of the current and emerging pharmacological therapies for this syndrome. Evidence Acquisition: In the present study, data on the IBS were principally collected via Google Scholar and PubMed, followed by articles in journals and libraries. Results: The pathophysiology of the IBS has yet to be fully elucidated. Global medical attempts, including pharmacological therapy and herbal remedies, aim at curing and/or subsiding pain, flatulence, diarrhea, and constipation. Conclusions: There is a need for new drugs in the setting of pharmacological therapy for the IBS. A new medical approach should include both novel and traditional drugs in order to reach to a desirable outcome for patients and improve their quality of life.